IMPACT-DCM Extension Study for Control Patients Initiated, Aastrom Biosciences (ASTM)
July 14th, 2010
No comments
ASTM initiated an extension study for control patients from the ongoing open-label Phase 2 IMPACT-DCM clinical trial in patients with dilated cardiomyopathy (DCM). Read more…
